• P V S N D Alekya Pharm.D, Interns of Jagan’s institute of pharmaceutical science, spsp Nellore, Andhra Pradesh,
  • M. Swarupa Pharm.D, Interns of Jagan’s institute of pharmaceutical science, spsp Nellore, Andhra Pradesh,
  • K. Mrudula Pharm.D, Interns of Jagan’s institute of pharmaceutical science, spsp Nellore, Andhra Pradesh,
  • SK. Mehaboob Pharm.D, Interns of Jagan’s institute of pharmaceutical science, spsp Nellore, Andhra Pradesh,
  • Narayana Swamy Palyam Department of Pharmacy Practice, Jagan’s institute of pharmaceutical science, spsp Nellore, Andhra Pradesh,
  • P.Venkatesh Principal of Jagan’s institute of pharmaceutical science, spsp Nellore, Andhra Pradesh,, India.


Background: Hypertension has become a significant problem in developing countries. The management of hypertension involves long term treatment & life style modification which will have greater impact on HRQoL. This study aims to give patient counseling regarding risk factors, life style modifications, pharmacological therapy & medication adherence in hypertension which in turn improves HRQoL.

Aim and objectives: To assess the effect of clinical pharmacist mediated counselling in hypertensive patients on health related quality of life.  Specific objectives: To assess the disease related knowledge of hypertensive patients, To assess the medication adherence of hypertensive patients,To design suitable patient information leaflet (PIL) on hypertension and its management use the same to educate the patients,To assess the effect of education on outcome of treatment (blood pressure level) and quality of life of these patients.

Methodology: Prospective observational study. The study was conducted in Jayabharath hospital, Nellore. which was conducted for a period of 6 months from June 2019- November-2019.Hypertensive patients, of either sex, above 18 years of age, with or without co-morbidities and Patient willing to give there informed consent to participate in the study are included in our study and the Pregnant hypertensive patients are excluded from the study.

Results and Discussion: At baseline there was no significant difference between the blood pressures, QoL score, adherence score, and KAP of the test and control groups. As patient in both group continued to see there physician regularly, both showed in improvement in blood pressure control at final follow up. However improvement in the test group blood pressure was more significant reduction (p<0.05). At final follow up, a significantly (p<0.05) some large number of patients in the test group had achieved better blood pressure control compared to the base line.

Keywords: Health Related Quality of Life, Hypertension Seventh report of the Joint national committee, Knowledge, attitude, practice


Download data is not yet available.


1.S H L Thomas chapter 19: Hypertension. Roger walker and Clive Edwards. Clinical pharmacy and Therapeutics. Churchil Livingstone. 2003:265-278.

2.Jacquelyn S Hunt, PharmD, Joseph Siemienczuk, MD. Impact of Educational Mailing on the Blood Pressure of Primary Care Patients with Mild Hypertension. Journal of General Internal Medicine. 2004: September

3.National Academies of sciences, Engineering and Medicine.2019.The role of NIH in drug development innovation and its impact on patient access:proceedings of a workshop. Washington, DC : The National academies press.https://doi.org/10.17226/25591.

4.Ramesh Adepu and Madhu’s .Influence of post discharge counseling on health outcomes in diabetic and hypertensive patients. AJPC.2011

5.Enabling novel treatments for nervous system disorders by improving methods for traversing the blood–brain barrier: Proceedings of a workshop. Washington, DC: The National Academies Press. doi: https://doi.org/10.17226/25044.2018

6.Exploring strategies to improve cardiac arrest survival: Proceedings of a workshop.Washington, DC: The National Academies Press. doi: 10.17226/23695. 2017.

7.Dietary Reference Intakes for sodium and potassium. Washington, DC: The National Academies Press. doi:https//doi.org/10.17226/25353. 2019.

8.Preparation and use of food-based dietary guidelines. Report of a joint FAO/WHO consultation. FAO/WHO. World Health Organ Tech RepSer. 1998; 880i-vi, 1–108; ISSN: 0512-3054.

9.Benowitz, N. L., and J. B. Fraiman. 2017. Cardiovascular effects of electronic cigarettes. Nature Reviews Cardiology 14(8):447–456.

10.Life-style development vs. modification, pp 15–8. In: Weiss SM, ed. Proceedings of the National Heart and Lung InstituteWorking Conference on health behavior. Bethesda, NIH, 1975. WG200 N279p 1975.

11.Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York, 19-22 June, 1946; signed on 22 July 1946 by the representatives of 61 States (Official Records of the World Health Organization, no 2, p. 100) and entered into force on 7 April 1948.

12.The WHOQOL Group. The World Health Organization Quality of Life Assessment (WHOQOL). Development and psychometric properties. Soc Sci Med 1998;46:1569-1585.

13.Gandek B, Sinclair SJ, Kosinski M, Ware JE Jr. Psychometric evaluation of the SF-36 health survey in Medicare managed care. Health Care Financ Rev 2004;25(4):5- 25.

14.Bakas T, McLennon SM, Carpenter JS, Buelow JM, Otte JL, Hanna KMH, et al.Systematic review of health-related quality of life models. Health Qual Life Outcomes. 2012;10(1):134–145.

15.Dunbar-Jacob J, Dwyer EJ. Compliance with antihypertensive regimens: a review of the research in the 1980s. Ann Behav Med. 1991;13(1):32–39.

16.Roca-Cusachs A, Sort D, Altimira J, Bonet R, Guilera E, Monmany J, Nolla J :The impact of a patient education programme in the control of hypertension. Journal of human hypertension. 1991.

17. Kurt J. Greenlund, PhD; Wayne H. Giles, MD; Nora L. Keenan, PhD; Physician Advice, Patient Actions, and Health-Related Quality of Life in Secondary Prevention of Stroke Through Diet and Exercise. AHA journal of stroke.2002.

18.Carina Hohmann. Roland. Radziwill. Health-Related Quality of Life afterIschemic Stroke: The Impact of Pharmaceutical Interventions on Drug Therapy (Pharmaceutical Care Concept). PMC. 2009-18-24.

19.Josiane Lima de Gusmao .Health-related quality of life and blood pressure control in hypertensive patients with and without complications. brazil.2001-44-51.

20.Paivi E.Korhonen, Sirkka-Liisa Kivela . Health-related quality of life and awareness of hypertension. cross sectional study. journal of hypertension. 2011.

21.V.Ramanarayana Reddy1, T.V.Narayana2, G.Nagarjuna Reddy .have performed a study titled as Impact of community pharmacy based patient education on quality of life in hypertension.2011:24-31.

22.Line Aubert, Pascal Bovet, Jean-Pierre Gervasoni, Anne Rwebogora, Knowledge, Attitudes, and Practices on Hypertension in a Country in Epidemiological Transition .Cross sectional study. Journal of the AHA in 1998.-141-148.

23.Ivon EJ Milder1, Anneke Blokstra .Lifestyle counseling in hypertension-related visits –analysis of video-taped general practice visits which observational study.BMC.2008.101-106

24.Jisha B Krishnan .Effectiveness on pharmaceutical care on quality of life in hypertensive patient .prospective study published in Asian journal of pharmaceutical and health sciences. 2012.

25.Hemant Mahajan1, Yasmeen Kazi. Assessment of KAP, Risk Factors and Associated Co-Morbidities in Hypertensive Patients IOSR Journal of Dental and Medical Sciences (IOSRJDMS). 2012.42-48
103 Views | 64 Downloads
How to Cite
P V S N D Alekya, P. V. S. N. D. A., M. S. M. Swarupa, K. M. K. Mrudula, S. M. SK. Mehaboob, narayana swamy palyam, and P. P.Venkatesh. “EFFECT OF CLINICAL PHARMACIST MEDIATED COUNSELLING IN HYPERTENSIVE PATIENTS ON HEALTH RELATED QUALITY OF LIFE”. World Journal of Current Medical and Pharmaceutical Research, July 2020, pp. 246-50, doi:10.37022/wjcmpr.vi.137.
Research Articles